Abnormalities of VLDL, IDL, and LDL characterize insulin-dependent diabetes mellitus

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 12, Issue 8, 1992, Pages 920-928

  Winocour, Peter H ^a,b   Durrington, Paul N ^a   Bhatnagar, Deepak ^a   Ishola, Monica ^a   Arrol, Sharon ^a   Mackness, Michael ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Cholesterol; Insulin dependent diabetes mellitus; Intermediate density lipoproteins; Lipoprotein composition; Phospholipids; Proteins; Triglycerides; Very low density lipoproteins

Indexed keywords

CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; PROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; MALE; MOLECULAR WEIGHT; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS; ULTRACENTRIFUGATION;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, INSULIN-DEPENDENT; HUMAN; LIPOPROTEINS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MIDDLE AGE; PHOSPHOLIPIDS; TRIGLYCERIDES;

EID: 0026628879     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.12.8.920     Document Type: Article

References (39)

1. Howard BV: Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987;28:613-628
2. Winocour PH, Durrington PN, Ishola M, Millier VF, Anderson DC: The prevalence of hyperlipidaemia and related clinical features in insulin-dependent diabetes mellitus. Q J Med 1989;70:265-276
3. Winocour PH, Durrington PN, Ishola M, Anderson DC, Cohen H: Influence of proteinuria on vascular disease, blood pressure and lipoproteins in insulin dependent diabetes mellitus. BMJ 1987;294:1648-1651
4. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D: Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361 662 men. Lancet 1986;2:934-937
5. Shepherd J, Betteridge DJ, Durrington PN, Laker M, Lewis B, Mann J, Millar JP, Reckless JPD, Thompson GR: Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations. BMJ 1987;295:1245-1246
6. Study Group of the European Atherosclerosis Society: Strategies for the prevention of coronary heart disease: A policy statement of the European Atherosclerosis Society. Eur Heart J 1987;8:77-88
7. The Expert Panel: Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988;148:36-69
8. Thelle DS, Shaper AG, Whitehead TP, Bullock DG, Ashby D, Patel I: Blood lipids in middle-aged British men. Br Heart J 1983;49:205-213
9. Slack J, Noble NN, Meade TW, North WRS: Lipid and lipoprotein concentrations in 1604 men and women in working populations in North-West London. BMJ 1977;2:353-356
10. Winocour PH, Durrington PN, Ishola M, Anderson DC: Lipoprotein abnormalities in insulin-dependent diabetic patients. Lancet 1986;1:1176-1178
11. Rivellese A, Riccardi G, Romano G, Giaccio R, Piatti L, Marotta G, Annuzzi G, Mancini M: Presence of very low density lipoprotein compositional abnormalities in Type 1 (insulin-dependent) diabetic patients: Effects of blood glucose optimisation. Diabetologia 1988;31:884-888
12. James RW, Pometta D: Differences in lipoprotein subfraction composition and distribution between type 1 diabetic men and control subjects. Diabetes 1990;39:1158-1164
13. Mancini M, Pauciullo P, Cortese C, Rubba P, Riccardi G, Rivellese A: Very low density lipoprotein: Qualitative abnormalities in patients with premature coronary heart disease and in patients with insulin dependent diabetes. Harm Metab Res 1988;19(suppl):13-15
14. Georgopoulos A, Rosengard AM: Abnormalities in the metabolism of postprandial and fasting triglyceride-rich lipoprotein subfractions in normal and insulin-dependent diabetic subjects: Effects of sex. Metabolism 1989;38:781-789
15. Joven J, Vilella E, Costa B, Turner PR, Richart C, Masana L: Concentrations of lipids and apolipoproteins in patients with clinically well-controlled insulin-dependent and non-insulin-dependent diabetes. Clin Chem 1989;35:813-816
16. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Gocke NM, Olsen BJ, Klenk PC: Measurement of protein using bicinichonic acid. Anal Biochem 1985;150:76-85
17. Lindgren FT, Jensen LC, Hatch FT: The isolation and quantitative analysis of serum lipoproteins, in Nelson GJ (ed): Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism. New York, John Wiley & Sons, Inc. 1972, pp 181-274
18. Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in normal serum. J Clin Invest 1955;34:1345-1353
19. Durrington PN, Whicher JT, Warren C, Bolton CH, Hartog M: A comparison of methods for the immunoassay of serum apolipoprotein B in man. Clin Chim Acta 1972;71:95-108
20. Bagdads JD, Subbaiah PV: Whole-plasma and high-density lipoprotein subfraction surface lipid composition in IDDM men. Diabetes 1989:38:1226-1230
21. Iwai M, Yoshino G, Matsushita M, Morita M, Matsuba K, Kazumi T, Baba S: Abnormal lipoprotein composition in normolipidemic diabetic patients. Diabetes Care 1990;13:792-796
22. Rosenstock J, Vega GL, Raskin P: Effect of intensive diabetes treatment on low-density lipoprotein apolipoprotein B kinetics in type 1 diabetes. Diabetes 1988;37:393-397
23. Pietri AO, Dunn FL, Grundy SM, Raskin P: The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type 1 diabetes mellitus. Diabetes 1983;32:75-81
24. Bagdade JD, Buchanan WE, Kuusi T, Taskinen M-R: Persistent abnormalities in lipoprotein composition in non-insulin-dependent diabetes after intensive insulin therapy. Arteriosclerosis 1990;10:232-239
25. Winocour PH, Tetlow L, Durrington PN, Ishola M, Millier V, Anderson DC: Apolipoprotein E polymorphism and lipoproteins in insulin treated diabetes mellitus. Atherosclerosis 1989;75:167-172
26. Walden CE, Knopp RH, Wahl PW, Beach KW, Strandness E: Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 1984;311:953-959
27. Semenkovich CF, Ostlund RE, Schectman KB: Plasma lipids in patients with Type 1 diabetes mellitus: Influence of race, gender, and plasma glucose control: Lipids do not correlate with glucose control in black women. Arch Intern Med 1989;149:51-56
28. Winocour PH, Durrington PN, Bhatnagar D, Ishola M, Mackness M, Arrol S: The influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition. Atherosclerosis 1991;89:49-57
29. Dullaart RPF, Groener JEM, Dikkeschei LD, Erkelens DW, Doorenbos H: Increased cholesteryl ester transfer activity in complicated Type 1 (insulin-dependent) diabetes mellitus: Its relationship with serum lipids. Diabctologia 1989;32:14-19
30. Taskinen M-R: Lipoprotein lipase in diabetes. Diabetes Metab Rev 1987;3:551-570
31. Lopes-Virella MF, Sherer GK, Lees AM, Wohltmann H, Mayfield R, Sagel J, LeRoy EC, Colwell JA: Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: Changes with metabolic control. Diabetologia 1982;22:430-436
32. Curtiss LK, Witztum JL: Plasma apolipoproteins AI, AII, B, CI and E are glucosylated in hyperglycaemic diabetic subjects. Diabetes 1985;34:452-461
33. Schemthaner G, Kostner GM, Dieplinger H, Prager R, Mulhauser I: Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin:cholesterol acyltransferase activity in diabetes mellitus. Atherosclerosis 1983;49:277-293
34. Mattock MB, Fuller JH, Maude PS, Keen H: Lipoproteins and plasma cholesterol esterification in normal and diabetic subjects. Atherosclerosis 1979;34:437-449
35. Tall A, Granot E, Brocia R, Tabas I, Hasler C, Williams K, Denke M: Accelerated transfer of cholesteryl esters in dyslipidemic plasma: Role of cholesteryl ester transfer protein. J Clin Invest 1987;79:1217-1225
36. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM: Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-1921
37. Kuksis A, Myher JJ, Geher K, Jones GJ, Breckenridge WC Feather T, Hewitt D, Little JA: Decreased phosphatidylcholine free cholesterol ratio as an indicator of risk for ischemic heart disease. Arteriosclerosis 1982;2:296-302
38. Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L: Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: A general population study. BMJ 1989;299:1127-1131
39. West KM, Ahuja MMS, Bennett P, Czyzyk A, Mateo de Acosta O, Fuller JH, Grab BB, Grabauskas V, Jarrett RJ, Kosaka K, Keen H, Knowlewski AS, Miki E, Schliak V, Teuscher A, Watkins PJ, Stober JA: The role of circulating glucose and triglyceride concentrations and their interaction with other 'risk factors' as determinants of arterial disease in nine diabetic populations from the WHO multinational study. Diabetes Care 1983;6:361-369